Pavlin‐Premrl D, Waters M, Thijs V, Mitchell PJ, Yassi N, Parsons MW, Weir L, Pesavento L, Maingard J, Cloud G, Stanislaus V, Ngun M, Campbell BCV. Symptomatic Intracranial Atherosclerosis in an Australian Context: Common and Underdiagnosed in Multiple Ethnic Groups. Stroke Vascular and Interventional Neurology. 2025;5(1):10.1161/svin.124.001397
Wrigley S, Cody R, Amadoru S, Huynh A, Galante O, Mandrawa C, Yassi N, Yates P. Prevalence and associations of cerebral microbleeds in an Australian memory clinic cohort. Internal Medicine Journal. 2024;:10.1111/imj.16614
Yassi N, Yogendrakumar V, Churilov L, Meretoja A, Wu T, Campbell BCV, Strbian D, Jeng J-S, Woodhouse LJ, Ovesen C, Law ZK, Gu H-Q, Nie X, Liu J, Ma HH, Zhao H, Bath PM, Liu L, Sprigg N, Donnan GA, Davis SM. Tranexamic Acid Within 4.5 Hours of Intracerebral Hemorrhage With the CTA Spot Sign. Neurology. 2024;103(12):10.1212/wnl.0000000000210104
Eratne D, Kang MJY, Lewis C, Dang C, Malpas C, Ooi S, Brodtmann A, Darby D, Zetterberg H, Blennow K, Berk M, Dean O, Bousman C, Thomas N, Everall I, Pantelis C, Wannan C, Cicognola C, Hansson O, Janelidze S, Santillo AF, Velakoulis D, Group TMS. Plasma neurofilament light outperforms glial fibrillary acidic protein in differentiating behavioural variant frontotemporal dementia from primary psychiatric disorders. Journal of the Neurological Sciences. 2024;467:10.1016/j.jns.2024.123291
Kataike VM, Desmond PM, Steward C, Mitchell PJ, Davey C, Yassi N, Bivard A, Parsons MW, Campbell BCV, Ng F, Venkatraman V. Iron changes within infarct tissue in ischemic stroke patients after successful reperfusion quantified using QSM. Neuroradiology. 2024;66(12):10.1007/s00234-024-03444-6
Holper S, Loveland PM, Churilov L, Italiano D, Watson R, Yassi N. Blood astrocyte biomarkers in AD: a systematic review and meta‐analysis. Alzheimer’s & Dementia. 2024;20(Suppl 2):10.1002/alz.090544
Rosenich E, Pirotta S, Cummins H, Norfolk M, Da Costa G, Yassi N, Churilov L, Sinnott RO, Brodtmann A, Pase MP, Barton C, Bush AI, Maruff P, Ayton D, Lim YY, Group BR. Baseline demographic, risk and cognitive characteristics of the final randomized sample enrolled in a decentralised multi‐domain lifestyle intervention trial (BetterBrains) to delay cognitive decline. Alzheimer’s & Dementia. 2024;20(Suppl 7):10.1002/alz.090564
Bhalala OG, Beamish J, Summerell P, Porter T, Laws SM, Kang M, Huq A, Eratne D, Walterfang M, Farrand S, Evans AH, Kelso W, Watson R, Yassi N, Velakoulis D, Loi SM. Multi‐omic blood biomarkers and cognitive profiles discriminate causes of younger‐onset neurocognitive symptoms: a cohort study. Alzheimer’s & Dementia. 2024;20(Suppl 2):10.1002/alz.085786
Yogendrakumar V, Balabanski AH, Johns H, Churilov L, Parsons NK, Beharry J, Weir L, Yassi N, Zhao H, Warwick A, Coote S, Langenberg F, Branagan L, Siddiqi W, Bivard A, Campbell BCV, Donnan GA, Davis SM, Mutimer C, Barker J, Santos AD, Ng JL, Ng F, Yan B, Ma M, Wong J, Park A, Sharobeam A, Valente M, Williams C, Ho S, Scarff P, Beltrame C, Shin C, Thijs V, Fink J, Barber A, Lin L. Evaluating the Safety and Efficacy of Telemedicine Physician Assessments on a Mobile Stroke Unit: Protocol for a Prospective Open-Label Blinded End-Point Randomized Controlled Trial.Journal of the American Heart Association. 2024;13(21):10.1161/jaha.124.036856
Sorby-Adams AJ, Marian OC, Bilecki IM, Elms LE, Yassi N, Hood RJ, Coller JK, Stuckey SM, Kimberly WT, Farr TD, Leonard AV, Thornton E, Vink R, Turner RJ. NK1 tachykinin receptor antagonist treatment reduces cerebral edema and intracranial pressure in an ovine model of ischemic stroke. Cerebrovascular and Brain Metabolism Reviews. 2024;44(10):10.1177/0271678×241241907